News

August 18, 2020

The Upcoming School Year is Expected to be Fraught with Uncertainty, Particularly for Children with Life-Threatening Food Allergies

August 10, 2020

Kaléo and the pan-Canadian Pharmaceutical Alliance (pCPA) Complete Negotiations for ALLERJECT® (epinephrine injection, USP) Auto-Injector for the Treatment of Serious Allergic Reactions Across Canadian Provinces

May 12, 2020

Kaléo Announces ALLERJECT® (epinephrine injection, USP) Auto-Injector Will Be Available for Canadians at Risk for Anaphylaxis Starting May 19, 2020

July 11, 2019

Walgreens and Kaléo Expand Retail Pharmacy Collaboration to Include AUVI-q® (epinephrine injection, USP) 0.1 mg, the Only FDA-Approved Epinephrine Auto-Injector for Infants and Toddlers, 16.5 – 33 lbs

December 12, 2018

Authorized Generic for EVZIO® (naloxone HCl injection) to be Available at a Reduced List Price of $178

September 6, 2018

Walgreens and Kaléo Partner to Address Epinephrine Auto-Injector Supply Issues, Providing Patients Access to AUVI-Q® (epinephrine injection, USP) Through Walgreens Locations Nationwide

August 29, 2018

AUVI-Q® (epinephrine injection, USP) Available in Canada Starting September 7

August 14, 2018

Kaléo Confirms U.S. Availability of AUVI-Q® (epinephrine injection, USP) Auto-injector for Back-to-School Season

April 26, 2018

With Life-Threatening Allergies Diagnosed in Infancy, kaléo Announces Availability of First and Only FDA-Approved Epinephrine Auto-Injector (EAI) for Infants and Toddlers Weighing 16.5 to 33 Pounds (7.5 to 15 kilograms)

April 18, 2018

NASCAR Driver Elliott Sadler Teams Up with kaléo about AUVI-Q® (Epinephrine Injection, USP) to Raise Awareness of Life-Threatening Allergies

April 5, 2018

EVZIO® (naloxone HCl injection, USP) Auto-Injector Now Available to Patients in Select States Without a Prescription Through Kaléo’s New Virtual Standing Order Pilot Program and to Government Agencies at a Direct Purchase Price

February 21, 2018

Cabell-Huntington Health Department and the City of Huntington Fire Department Officials Named Co-Recipients of the 2017 kaléo Cares Award

January 11, 2018

More than 5000 Lives Reported Saved with Help of EVZIO® (naloxone HCl injection) Auto-injectors

November 20, 2017

U.S. FDA Approves Kaléo’s AUVI-Q® (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children

October 24, 2017

Kaléo Along with National Advocacy Organizations Launch the “No Appetite for Bullying” Initiative

September 1, 2017

Kaléo Donates Thousands of AUVI-Q® (epinephrine injection, USP) and EVZIO® (naloxone HCl injection) Auto-injectors to Hurricane Harvey Relief Efforts

August 7, 2017

Kaléo Announces AUVI-Q® (epinephrine injection, USP) Charitable Donation Program for All Public Elementary Schools in the United States

July 27, 2017

U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaléo Specifically for Infants and Small Children

June 22, 2017

Kaléo Donates 250,000th EVZIO® (naloxone HCl injection) Auto-injector to Help Fight Opioid Overdose Epidemic

January 19, 2017

Kaléo Announces U.S. Availability and Pricing to Patients of Auvi-Q® (Epinephrine Injection, USP) Auto-Injector, For Life-Threatening Allergic Reactions

December 22, 2016

McShin Foundation Named Recipient of the 2016 kaléo Cares Award

October 26, 2016

Kaléo Announces 2017 U.S. Return Of Auvi-Q® (Epinephrine Injection, USP) Auto-Injector For Life-Threatening Allergic Reactions

September 8, 2016

Kaléo Presents Studies at PAINWeek 2016 Comparing Naloxone Intramuscular Injection and Naloxone Intranasal Administration

March 28, 2016

More than 1000 Lives Reported Saved with Help of EVZIO® (naloxone HCl injection) Auto-injectors

January 25, 2016

kaléo Announces the Award of its 100th Patent

January 12, 2016

More than 600 Lives Reported Saved Since Launch of the “kaléo Cares” EVZIO® (naloxone HCl injection) Auto-injector Donation Program

October 5, 2015

Chelsea Laliberte, Co-Founder of Live4Lali, Named Recipient of the First Annual Kaléo Cares Award

September 29, 2015

kaléo to Donate 50,000 EVZIO® (naloxone HCl injection) Auto-Injectors in Honor of the UNITE to Face Addiction Rally

September 2, 2015

New Campaign Urges It’s Time “America Starts Talking” More Openly About Safe Prescription Opioid Pain Management

August 31, 2015

More than 100 Lives Reported Saved Since Launch of the “kaleo Cares” EVZIO® (naloxone HCl injection) Donation Program

January 26, 2015

Kaléo and the Clinton Foundation’s Health Matters Initiative
 Unite to Reduce Prescription Opioid-Related Deaths

January 16, 2015

Police Reverse First Opioid Overdose Using EVZIO® (naloxone HCl injection) Provided through Kaléo Cares Donation Program

October 27, 2014

Kaléo Supports Opioid Overdose Emergency Treatment Efforts with EVZIO™ (naloxone hcl injection) Donations to Local Law Enforcement Agencies

July 10, 2014

EVZIO™ (naloxone HCl injection) Auto-Injector Now Available in the United States for the Emergency Treatment of Opioid Overdose

April 7, 2014

Kaléo announces $150 million debt financing to support commercialization of EVZIO™

April 3, 2014

FDA Approves Kaleo’s EVZIO™ for the Emergency Treatment of Opioid Overdose

January 6, 2014

Intelliject, Inc. announces name change to kaléo

November 14, 2013

Intelliject, Inc. wins prestigious medication safety award

May 29, 2012

Intelliject, Inc. announces $15 million debt financing to accelerate targeted pipeline development